Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know

Dermatol Clin. 2020 Apr;38(2):233-238. doi: 10.1016/j.det.2019.10.008. Epub 2019 Nov 23.

Abstract

HIV remains an important public health concern in the United States, particularly for men who have sex with men (MSM) and transgender persons. With HIV preexposure prophylaxis (PrEP), persons who are HIV-uninfected take antiretroviral medications to prevent HIV infection. The most common PrEP regimen involves taking a single pill daily and is very effective in reducing risk of HIV infection, with few adverse effects. Barriers to PrEP access exist for MSM and transgender persons. Dermatologists can help combat the ongoing HIV epidemic among MSM, transgender persons, and others by understanding why, when, and how PrEP should be considered as an HIV prevention approach.

Keywords: HIV; Men who have sex with men; PrEP; Prevention; Transgender.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Dermatologists
  • HIV Infections / prevention & control*
  • Humans
  • Pre-Exposure Prophylaxis / methods*
  • Pre-Exposure Prophylaxis / statistics & numerical data
  • Referral and Consultation
  • Sexual and Gender Minorities*
  • Transgender Persons

Substances

  • Anti-Retroviral Agents